Kristin Neuman to Speak About MPEG LA’S CRISPR Pool License at NewYorkBIO and AIPLA

(DENVER, CO, US – 10 May 2017) – World licensing leader MPEG LA, LLC today announced that Kristin Neuman, MPEG LA’s Executive Director of Biotechnology Licensing, will speak at New York BIO’s Annual Meeting on May 11 in New York City and at the American Intellectual Property Law Association (AIPLA) Spring Meeting on May 17 in San Diego. Ms. Neuman will discuss MPEG LA’s CRISPR-Cas9 Joint Licensing Platform as the market’s best hope to streamline CRISPR licensing giving businesses the predictability they need to unleash CRISPR’s full potential.

MPEG LA, whose pioneering pool license model helped assure the success of digital video in the consumer electronics industry with convenient one-stop access to relevant intellectual property, recently invited holders of CRISPR-Cas9 patents to participate in the creation of a global CRISPR-Cas9 Joint Licensing Program. For information about the CRISPR-Cas9 Joint Licensing Platform, please go to our CRISPR page.

Relevant Links

English PDF